Insights from RIAR Consulting
Explore regulatory updates, pharmaceutical manufacturing developments, compliance challenges and emerging industry trends.
All articles
Through technical analysis and industry-focused perspectives, RIAR Consulting examines the developments shaping regulated markets and manufacturing operations.
Regulated Manufacturing & Regulatory IntelligenceInterTabac 2026: What We Heard About the Future of Regulated Nicotine Manufacturing
From global industry conversations to continuous risk intelligence: what manufacturers told us at InterTabac | NUBIZ | InterSupply 2026.
Read the article
Pharmaceutical Manufacturing & Supply ChainFrom Manufacturing Problems to Medicine Shortages
What the Pharmathen–paliperidone case teaches us about manufacturing intelligence, and why a medicine shortage is rarely just a supply-chain event.
Read the article
Tobacco Packaging & Printing SolutionsPrinting Ink for Tobacco and Cigarette
Premium printing inks for cigarette, tobacco and packaging applications: print quality, durability, security and regulatory compliance.
Read the article
Europe Market Entry StrategyIndia–EU Trade Deal: Impact on the European Pharmaceutical Market and Consulting Opportunities for Indian Companies
Why the India–EU FTA is a regulatory activity multiplier for Indian pharma and medtech companies entering Europe.
Read the article
Industry Insights & Thought LeadershipThe New Pharma Playbook (2025–2030)
Data-driven intelligence, AI-powered execution, patient-centric design and value-based outcomes: the playbook for the decade ahead.
Read the article
SFDA MDS-G27SFDA’s New Digital Health Regulatory Guidance (MDS-G27): What You Must Know
How SFDA’s MDS-G27 classifies, assesses and regulates digital health products in Saudi Arabia, and what it means for developers.
Read the article
SFDA Regulatory UpdatesSFDA Releases Version 3.0 of Verification & Abridged Pathways Guideline
What changes in Version 3.0 of the SFDA Verification & Abridged Pathways Guideline, effective January 2026, and why it matters.
Read the article
SFDA Product Registration – Saudi ArabiaA Complete Guide to SFDA Product Registration in Saudi Arabia — Insights from RIAR Consulting
Who can apply, the key steps, timelines, post-approval duties and best practices for registering products with the SFDA.
Read the article
Pharmaceutical Policy, Innovation & ComplianceWhy India Is Falling Behind China — and What Must Change to Achieve Competitive Parity
Volume versus value, API dependency, the innovation gap and regulatory agility: why the gap exists and how India can close it.
Read the article
SFDASFDA Registration Made Simple: Why RIAR Consulting Is the Trusted Regulatory Partner for Saudi Market Entry
From product classification to MDMA approvals and post-market compliance: how RIAR Consulting supports accurate, compliant market entry into Saudi Arabia.
Read the article
Topics we write about
Our insights are intended to help manufacturers, regulatory professionals and industry stakeholders better understand changing requirements, operational challenges and opportunities across the life-sciences sector.
Have any question?
RIAR Consulting supports pharmaceutical, medical device, cosmetic and emerging healthcare companies with structured regulatory strategies, submission management and market-entry support, and manufacturing intelligence through VERA 2.0.